DANIELLE RANDOLPH: Open Payments
NPI 1730886433 · WESTWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 20 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $368 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $139 |
| Myriad Genetic Laboratories, Inc. | 1 | $96 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| Caris MPI, Inc. | 2 | $48 |
| Incyte Corporation | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| PFIZER INC. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Eisai Inc. | 1 | $14 |
Products named: MYRISK, ENHERTU, KEYTRUDA, MI CANCER SEEK, KISQALI, MONJUVI, IBRANCE, JEMPERLI.
Industry payments across KS — which companies pay providers there.
